×
Back to Agenda
Session 5: Biologics - Innovation and Challenges from CMC Perspective
Session Chair(s)
Ho Jung Oh
Director NIFDS, Ministry of Food and Drug Safety, Korea, Republic of
Speaker(s)
JunTae Park
Senior vice president of licensing and regulatory affairs, Helixmith, Korea, Republic of
CMC-Related Technical And Regulatory Aspects For Development Of Biotherapeutic Products
Sangyoon Lee
, Celltrion, United States
Antibody Drug Manufacturing And Quality Control (Tentative)
Have an account?